In this issue:
Cetuximab + irinotecan for quadruple wild-type mCRC
SIRT improves OS in right-sided primary mCRC
VEGFR inhibition prolongs OS in mCRC
PARP inhibition for refractory mCRC?
Adjuvant chemotherapy in colon cancer
FOLFOX or CAPOX in stage II to III colon cancer
Tree nuts improve survival in colon cancer
Full dosing for obese patients with colon cancer
Predictors of irinotecan toxicity in CRC
NAR score predictive of DFS in rectal cancer
Please login below to download this issue (PDF)